| Synonym | Cell Type | QPCR Expression | Normalized To | Data From |
|---|
| Zfp30 | DN1 | -3.42 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | DN1 | -3.6 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp30 | DN2 | -3.59 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | DN2 | -4.1 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp30 | DN3a | -3.46 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | DN3a | -3.82 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp30 | DN3b | -4.52 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | DN3b | -4.74 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp30 | DN4 | -4.54 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | DN4 | -5.52 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp30 | LSK- | -4.2 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK- | -4.3 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK- | -3.77 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK- | -3.14 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK- | -2.96 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK- | -3.11 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp30 | LSK+ | -3.14 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK+ | -2.96 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK+ | -3.11 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK+ | -4.2 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK+ | -4.3 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | LSK+ | -3.77 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp30 | PreM | -5.05 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | PreM | -6.3 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | PreM | -5 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | PreM | -5.06 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | PreM | -6.3 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | PreM | -5 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp30 | ProB | -3.92 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProB | -4.06 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProB | -3.92 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProB | -3.92 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProB | -4.06 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProB | -3.92 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp30 | ProT | -3.4 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProT | -3.52 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProT | -3.52 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProT | -3.39 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProT | -3.52 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp30 | ProT | -3.47 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |